Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Management After Interruption or Discontinuation of MomelotinibRisk of ReboundSudden interruption or early termination of momelotinib therapy may lead to rapid rebound or worsening···【more】
Article source：Captain MedicineRelease date：2026-06-23Recommended：217
Major Cardiovascular Event Risk with MomelotinibRisk BackgroundMomelotinib belongs to the JAK inhibitor class. In studies of similar agents for rheumatoid arthritis, an increased i···【more】
Article source：Captain MedicineRelease date：2026-06-23Recommended：205
Momelotinib: Risk of Decreased Platelet and White Blood Cell CountsMomelotinib may cause or worsen decreases in platelet and white blood cell counts. Thrombocytopenia increases ble···【more】
Article source：Captain MedicineRelease date：2026-06-22Recommended：223
Mechanism of Action of MomelotinibMyelofibrosis (MF) is a rare blood cancer, and when it coexists with anemia, patients often face challenges beyond a single dimension. Anemia itse···【more】
Article source：Captain MedicineRelease date：2026-06-22Recommended：207
Tepotinib: Common and Serious Adverse ReactionsThis drug can cause various adverse reactions. Very common (incidence >10%) include: fluid retention leading to edema (especially ···【more】
Article source：Captain MedicineRelease date：2026-06-18Recommended：239
Standard Dosage and Adjustment Principles for TepotinibThe recommended dose is 2 tablets (i.e., 450 mg) orally once daily, taken with or shortly after a meal to ensure adequate abs···【more】
Article source：Captain MedicineRelease date：2026-06-18Recommended：192
Basic Characteristics and Composition of TepotinibTepotinib is a film-coated tablet containing 225 mg of the active ingredient tepotinib. Tepotinib is a prescription drug and must ···【more】
Article source：Captain MedicineRelease date：2026-06-17Recommended：199
Absolute Contraindications and Allergy Risks for TepotinibTepotinib is strictly contraindicated in patients with known hypersensitivity to tepotinib or to any of its excipients. If···【more】
Article source：Captain MedicineRelease date：2026-06-17Recommended：178
Core Mechanism and Indications of TepotinibTepotinib is a precision targeted therapy that works by specifically inhibiting the MET protein, which drives cancer growth. By blocking ···【more】
Article source：Captain MedicineRelease date：2026-06-17Recommended：180
Managing Side Effects During Tepotinib TreatmentDuring the use of tepotinib, if severe side effects occur, patients should not self-manage but rely on professional guidance from he···【more】
Article source：Captain MedicineRelease date：2026-06-16Recommended：236
How to properly take Tepotinib and manage missed dosesTepotinib must be taken strictly as prescribed by your doctor; do not change the dose or stop treatment on your own. The stand···【more】
Article source：Captain MedicineRelease date：2026-06-16Recommended：237
Tepotinib-Associated Risk of Liver Function Abnormalities and Liver FailureTepotinib may cause abnormalities in liver function blood test results, and one patient in clinical trial···【more】
Article source：Captain MedicineRelease date：2026-06-15Recommended：228
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
